Gohar Mosoyan

2.4k total citations
12 papers, 208 citations indexed

About

Gohar Mosoyan is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Gohar Mosoyan has authored 12 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Nephrology, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Epidemiology. Recurrent topics in Gohar Mosoyan's work include Chronic Kidney Disease and Diabetes (7 papers), Diabetes Treatment and Management (3 papers) and Sepsis Diagnosis and Treatment (2 papers). Gohar Mosoyan is often cited by papers focused on Chronic Kidney Disease and Diabetes (7 papers), Diabetes Treatment and Management (3 papers) and Sepsis Diagnosis and Treatment (2 papers). Gohar Mosoyan collaborates with scholars based in United States, Netherlands and Australia. Gohar Mosoyan's co-authors include Steven G. Coca, Girish N. Nadkarni, Michael Donovan, Lili Chan, Patricia Connolly, Fadi Salem, Scott M. Damrauer, Barbara Murphy, James R. McCullough and Joseph A. Vassalotti and has published in prestigious journals such as Blood, The FASEB Journal and Journal of the American Society of Nephrology.

In The Last Decade

Gohar Mosoyan

11 papers receiving 206 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gohar Mosoyan United States 8 100 64 38 28 21 12 208
Yeshwanter Radhakrishnan United States 8 77 0.8× 18 0.3× 3 0.1× 18 0.6× 23 1.1× 24 214
Fnu Sapna United States 8 15 0.1× 36 0.6× 10 0.3× 21 0.8× 4 0.2× 21 221
Anand Thakarakkattil Narayanan Nair United Kingdom 8 10 0.1× 190 3.0× 18 0.5× 20 0.7× 79 3.8× 8 329
Matthieu Wargny France 9 13 0.1× 40 0.6× 3 0.1× 23 0.8× 24 1.1× 22 153
Neha Debnath United States 5 58 0.6× 10 0.2× 9 0.2× 13 0.5× 9 0.4× 16 147
Martina Troll Germany 4 12 0.1× 11 0.2× 16 0.4× 22 0.8× 4 0.2× 6 125
Runqing Mu China 9 20 0.2× 15 0.2× 6 0.2× 4 0.1× 13 0.6× 20 268
Marcus A. Urey United States 7 40 0.4× 7 0.1× 51 1.3× 47 1.7× 7 0.3× 32 458
Fatima Qafoud Qatar 3 13 0.1× 26 0.4× 16 0.4× 8 0.3× 48 2.3× 5 210
Evgenija Homšak Slovenia 8 9 0.1× 14 0.2× 6 0.2× 7 0.3× 19 0.9× 24 232

Countries citing papers authored by Gohar Mosoyan

Since Specialization
Citations

This map shows the geographic impact of Gohar Mosoyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gohar Mosoyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gohar Mosoyan more than expected).

Fields of papers citing papers by Gohar Mosoyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gohar Mosoyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gohar Mosoyan. The network helps show where Gohar Mosoyan may publish in the future.

Co-authorship network of co-authors of Gohar Mosoyan

This figure shows the co-authorship network connecting the top 25 collaborators of Gohar Mosoyan. A scholar is included among the top collaborators of Gohar Mosoyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gohar Mosoyan. Gohar Mosoyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Varricchio, Lilian, et al.. (2025). Thrombocytopenia in myelofibrosis is characterized by inflammatory megakaryocytes with reduced G6B expression. Blood. 146(13). 1612–1624. 1 indexed citations
3.
Nadkarni, Girish N., Gohar Mosoyan, Michael K. Hansen, et al.. (2023). Derivation and independent validation of kidneyintelX .dkd: A prognostic test for the assessment of diabetic kidney disease progression. Diabetes Obesity and Metabolism. 25(12). 3779–3787. 7 indexed citations
4.
Liu, Caroline, Neha Debnath, Gohar Mosoyan, et al.. (2022). Systematic Review and Meta-Analysis of Plasma and Urine Biomarkers for CKD Outcomes. Journal of the American Society of Nephrology. 33(9). 1657–1672. 35 indexed citations
5.
Liu, Caroline, Neha Debnath, Gohar Mosoyan, et al.. (2022). Plasma and Urine Biomarkers for CKD Outcomes: A Systematic Review and Meta-Analysis. Journal of the American Society of Nephrology. 33(11S). 915–915. 1 indexed citations
6.
Lam, David W., Girish N. Nadkarni, Gohar Mosoyan, et al.. (2022). Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial. American Journal of Nephrology. 53(1). 21–31. 17 indexed citations
8.
Chan, Lili, Girish N. Nadkarni, James R. McCullough, et al.. (2021). Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease. Diabetologia. 64(7). 1504–1515. 92 indexed citations
9.
Chan, Lili, Kusum S. Mathews, Deena R. Altman, et al.. (2021). Hyperglycemia is Associated With Increased Mortality in Critically Ill Patients With COVID-19. Endocrine Practice. 27(2). 95–100. 25 indexed citations
10.
Chan, Lili, Kusum S. Mathews, Deena R. Altman, et al.. (2021). Hyperglycemia Is Associated With Increased Mortality in Critically Ill Patients With COVID-19. Journal of the Endocrine Society. 5(Supplement_1). A343–A344. 1 indexed citations
11.
Egerman, Marc A., Jenny Wong, Runxia Tian, et al.. (2020). Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease. The FASEB Journal. 34(12). 16191–16204. 12 indexed citations
12.
Patel, Ami B., Danuta Jarocha, Gohar Mosoyan, et al.. (2019). Pre‐clinical development of a cryopreservable megakaryocytic cell product capable of sustained platelet production in mice. Transfusion. 59(12). 3698–3713. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026